Document is current
Any future updates will be listed below
-
Authors
Scarabello, Anna
Zanuttini, Luca
Schettino, Martino
Muccioli, Lorenzo
Ferri, Lorenzo
Bisulli, Francesca https://orcid.org/0000-0002-1109-7296
Naldi, Ilaria
Volpi, Lilia
Michelucci, Roberto
Boni, Antonella
Gentile, Valentina
Zucchelli, Mino
Tinuper, Paolo
Martinoni, Matteo
Mostacci, Barbara
-
Funding
Funding for this research was provided by:
Alma Mater Studiorum - Università di Bologna
- License Information
-
More Information
Article History
Received: 6 October 2025
Accepted: 27 January 2026
First Online: 10 February 2026
Declarations
:
: This study was approved by the institutional Ethics Committee of IRCCS Isituto delle Scienze Neurologiche di Bologna. Informed consent was obtained from all individual participants included in the study. All procedures were performed in accordance with the ethical standards of the Declaration of Helsinki and applicable local laws and regulations.
: B.M. has received personal fees from LivaNova, Angelini, Eisai, Lusofarmaco, and Sanofi. She has served as an investigator in clinical trials for which her institution received compensation from LivaNova, Xenon, and Takeda, all outside the scope of the submitted work. P.T. has served as an investigator in clinical trials for which his institution received compensation from LivaNova, also outside the scope of the submitted work. The remaining authors have no conflicts of interest.q
